ICM
MTCH icon

Invenomic Capital Management’s Match Group MTCH Stock Holding History

Invenomic Capital Management’s Portfolio MTCH Stock Details MTCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-381,866
Closed -$11.8M – 168
2025
Q2 		$11.8M Sell
381,866
-765,925
-67% -$22.9M 0.67% 55
2025
Q1 		$35.8M Buy
1,147,791
+40,915
+4% +$1.34M 1.81% 11
2024
Q4 		$36.2M Buy
1,106,876
+724,818
+190% +$24.8M 1.72% 9
2024
Q3 		$14.5M Sell
382,058
-74,073
-16% -$2.59M 0.79% 42
2024
Q2 		$13.9M Buy
+456,131
New +$14.4M 0.67% 49
2023
Q3 		– Sell
-252,245
Closed -$10.6M – 160
2023
Q2 		$10.6M Buy
252,245
+94,415
+60% +$3.45M 0.53% 55
2023
Q1 		$6.06M Buy
+157,830
New +$6.88M 0.34% 83

Other funds holding MTCH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's MTCH Position: Q3 2025 in Review

Invenomic Capital Management sold out of Match Group (MTCH) in Q3 2025, closing a stake of 381,866 shares — an estimated $11.8M sold.

Invenomic Capital Management first reported a position in MTCH in Q1 2023 and held it in 7 quarters. The position peaked at $36.2M in Q4 2024. 617 funds tracked by Wall St. Rank hold MTCH as of Q3 2025.

  • Invenomic Capital Management reported no remaining Match Group position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 381,866 Match Group shares in Q3 2025, an estimated $11.8M.
  • Invenomic Capital Management first reported a position in Match Group in Q1 2023 and held it in 7 quarters.
  • Invenomic Capital Management's Match Group position peaked at $36.2M in Q4 2024.
  • 617 funds tracked by Wall St. Rank held Match Group as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.